ask="20.45"
ask_size="700"
average_daily_volume="423507"
bid="16.26"
bid_size="200"
book_value="3.21"
change="-0.11"
change_from_200_day_moving_average="5.18"
change_from_50_day_moving_average="0.16"
change_from_52_week_high="-3.48"
change_From_52_week_low="14.25"
change_in_percent="-0.54%"
close="20.27"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.48"
ex_dividend_date="N/A"
float_shares="7150000"
high="20.67"
high_52_weeks="23.75"
last_trade_date="3/10/2017"
last_trade_price="20.27"
last_trade_size="2626"
last_trade_time="4:00pm"
low="20.11"
low_52_weeks="6.02"
market_capitalization="201.75M"
moving_average_200_day="15.09"
moving_average_50_day="20.11"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.63"
open="20.58"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+34.32%"
percent_change_from_50_day_moving_average="+0.80%"
percent_change_from_52_week_high="-14.65%"
percent_change_from_52_week_low="+236.71%"
previous_close="20.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.35"
price_per_sales="3588.60"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.00"
stock_exchange="NGM"
symbol="ZYNE"
volume="163175"
weeks_range_52="6.02 - 23.75"
